Quality Assurance Manager
ITF Therapeutics
Quality Assurance Manager
ITF Therapeutics
Develops and commercializes rare-disease therapies
Reporting to: Director, Quality Assurance
About This Role
As part of the Quality team, you will play a key role in the day-to-day management of product quality complaints, owning the complaints process and training, and supporting the Quality team. In partnership with the US Head of Quality, you will ensure that appropriate complaints processes are in place for the US organization, aligned with the global and local Quality strategy and requirements.
This role is onsite at least four days a week, and candidates must be willing and able to come to our office in Concord, MA.
What You’ll Do
Who You Are:
Working with our fast-paced, growing team, you bring post-marketing Quality expertise to ensure the US complaints program meets the highest standards. With a sharp eye for compliance and detail, you have the ability to manage multiple priorities while remaining consistently focused on patient safety.
Required Skills & Experience:
Preferred Skills:
Additional Information:
The base compensation range for this role is $140,000 - $160,000. Compensation is determined through an analytical approach utilizing a combination of factors including, but not limited to, relevant skills & experience, job location, and internal equity.
Develops and commercializes rare-disease therapies
ITF Therapeutics is a division of Italfarmaco S.p.A. focused on developing and commercializing treatments for rare diseases in the U.S., especially Duchenne Muscular Dystrophy (DMD). The company works on early-stage research and clinical development, partnering with patient advocacy groups and clinical leaders to align programs with patient needs. Its lead program is DUVYZAT (givinostat), a histone deacetylase (HDAC) inhibitor aimed at DMD. Revenue comes from bringing these specialized therapies to market. Compared with competitors, ITF Therapeutics emphasizes collaboration with patient groups and clinicians, a pipeline-focused early-development approach, and a specialty in HDAC inhibitors for rare diseases. The company’s goal is to deliver effective treatments for rare-disease patients by advancing promising therapies through development and into commercialization.
Explore more opportunities at ITF Therapeutics